Betrixaban
In vial of 0.5 g net
TargetMol Chemicals Inc.
Product Overview
Product / Grade Name
Betrixaban
Maker Name
Product Description
Betrixaban (PRT054021) is a non-vitamin K oral anticoagulant whose action is driven by the competitive and reversible inhibition of the factor Xa [1]. It was selected among all lead compounds due to its low hERG channel affinity while sustaining its factor Xa inhibition capacity [3]. Betrixaban, now developed by Portola Pharmaceuticals Inc., is prescribed as a venous thromboembolism (VTE) prophylactic for adult patients with moderate to severe restricted motility or with other risks for VTE [2]. VTE can be manifested as deep vein thrombosis or pulmonary embolism and it is a leading cause of preventable death in hospitalized patients [4].
Hazard Classification
UN Number
:IMGD Class
:Packing Group
:
Visual Overview
Corporate Video